Skip to main content

Table 2 Statistics for experiment 2

From: Sex differences in a mouse model of multiple sclerosis: neuropathic pain behavior in females but not males and protection from neurological deficits during proestrus

Measure Two-way RM ANOVA (treatment × time (BL–day 43)) Two-way RM ANOVA (treatment × time (days 60–90))
Clinical scores Figure 3A Day: F37,1221 = 21.3, P < 0.001 Day: F2,30 = 0.8, P = 0.4
Treatment: F1,33 = 21.7, P < 0.001 Treatment: F1,15 = 0.003, P = 0.9
Day × treatment: F37,1221 = 4.1, P < 0.001 Day × treatment: F2,30 = 1.7, P = 0.19
Grip strength Figure 3B Day: F13,429 = 17.9, P < 0.001 Day: F2,30 = 4.7, P < 0.05
Treatment: F1,33 = 22.6, P < 0.001 Treatment: F1,15 = 0.16, P = 0.6
Day × treatment: F13,429 = 0.9, P = 0.5 Day × treatment: F2,30 = 1.4, P = 0.2
Weight Figure 3C Day: F36,1188 = 76.3, P < 0.001 Day: F2,30 = 17.1, P < 0.001
Treatment: F1,33 = 1.0, P = 0.3 Treatment: F1,15 = 0.5, P = 0.4
Day × treatment: F36,1188 = 0.5, P = 0.9 Day × treatment: F2,30 = 0.6, P = 0.4
Mechanical thresholds Figure 3D Day: F13,429 = 5.5, P < 0.001 Day: F2,30 = 30.4, P = 0.06
Treatment: F1,33 = 20.9, P < 0.001 Treatment: F1,15 = 0.5, P = 0.4
Day × treatment: F13,429 = 2.8, P < 0.01 Day × treatment: F2,30 = 1.0, P = 0.3
Acetone withdrawal Figure 3E Day: F13,429 = 11.1, P < 0.001 Day: F2,30 = 0.5, P = 0.5
Treatment: F1,33 = 8.9, P < 0.01 Treatment: F1,15 = 0.2, P = 0.6
Day × treatment: F13,429 = 2.0, P = 0.06 Day × treatment: F2,30 = 1.6, P = 0.2
Heat latency Figure 3F Day: F7,231 = 1.8, P = 0.07 -
Treatment: F1,33 = 1.9, P = 0.17
   Day × treatment: F7,231 = 0.3, P = 0.9  
  1. Treatment conditions: CFA, n = 17 (BL–day 43) or n = 8 (days 60–90). CFA + MOG35-55, n = 18 (BL–day 43) or n = 9 (days 60–90).